Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 8
2008 18
2009 45
2010 54
2011 54
2012 52
2013 32
2014 44
2015 44
2016 33
2017 28
2018 39
2019 41
2020 42
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

485 results
Results by year
Filters applied: . Clear all
Page 1
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.
Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, Levi M, Samama CM, Thachil J, Giannis D, Douketis JD; Subcommittee on Perioperative, Critical Care Thrombosis, Haemostasis of the Scientific, Standardization Committee of the International Society on Thrombosis and Haemostasis. Spyropoulos AC, et al. J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929. J Thromb Haemost. 2020. PMID: 32459046 Free PMC article.
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.
Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, Kahn SR, Rahman M, Rajasekhar A, Rogers FB, Smythe MA, Tikkinen KAO, Yates AJ, Baldeh T, Balduzzi S, Brożek JL, Ikobaltzeta IE, Johal H, Neumann I, Wiercioch W, Yepes-Nuñez JJ, Schünemann HJ, Dahm P. Anderson DR, et al. Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975. Blood Adv. 2019. PMID: 31794602 Free PMC article.
Trousseau's syndrome: cancer-associated thrombosis.
Ikushima S, Ono R, Fukuda K, Sakayori M, Awano N, Kondo K. Ikushima S, et al. Jpn J Clin Oncol. 2016 Mar;46(3):204-8. doi: 10.1093/jjco/hyv165. Epub 2015 Nov 6. Jpn J Clin Oncol. 2016. PMID: 26546690 Review.
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA, Bodalia PN, Bryden PA, Davies PA, López-López JA, Okoli GN, Thom HH, Caldwell DM, Dias S, Eaton D, Higgins JP, Hollingworth W, Salisbury C, Savović J, Sofat R, Stephens-Boal A, Welton NJ, Hingorani AD. Sterne JA, et al. Health Technol Assess. 2017 Mar;21(9):1-386. doi: 10.3310/hta21090. Health Technol Assess. 2017. PMID: 28279251 Free PMC article. Review.
We evaluated cost-effectiveness using discrete-time Markov models. RESULTS: Apixaban (Eliquis(), Bristol-Myers Squibb, USA; Pfizer, USA) [5 mg bd (twice daily)] was ranked as among the best interventions for stroke prevention in AF, and had the highest expected net …
We evaluated cost-effectiveness using discrete-time Markov models. RESULTS: Apixaban (Eliquis(), Bristol-Myers Squibb, USA; Pfizer, …
485 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page